Injury-induced expression of cytokeratins 8 and 18 by vascular smooth muscle cells requires concurrent activation of cytoskeletal and growth factor receptors

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 5, 2008, Pages 223-231

  Moon, Michael C ^a,b   Yau, Lorraine ^a,b   Wright, Brenda ^b   Zahradka, Peter ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Cytokeratin; Extracellular matrix; Phenotype; Restenosis; Signal transduction

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CYTOKERATIN 18; CYTOKERATIN 8; GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE PRODUCTION; CYTOSKELETON; EXTRACELLULAR MATRIX; FEMORAL ARTERY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MITOGENESIS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN INDUCTION; RESTENOSIS; SIGNAL TRANSDUCTION; SWINE; VASCULAR SMOOTH MUSCLE;

ANGIOPLASTY, BALLOON; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CELLS, CULTURED; COLLAGEN; CORONARY VESSELS; CYTOSKELETAL PROTEINS; FEMORAL ARTERY; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-18; KERATIN-8; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ORGAN CULTURE TECHNIQUES; PHENOTYPE; PROTEIN KINASE INHIBITORS; RADIAL ARTERY; RECEPTORS, GROWTH FACTOR; SERUM; SWINE; TIME FACTORS; UP-REGULATION;

EID: 43949131394     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-019     Document Type: Article

References (24)

1. Bauriedel, G., Schewe, K., Windstetter, U., Brandl, R., Becker, H.M., Jahn, L., and Hofling, B. 1991. Differential cytokeratin expression in cultivated smooth muscle cells of primary and re-stenosed plaque tissue? Vasa Suppl. 32: 216-219. PMID:1722913.
2. Buhler, H., and Schaller, G. 2005. Transfection of keratin 18 gene in human breast cancer cells causes induction of adhesion proteins and dramatic regression of malignancy in vitro and in vivo. Mol. Cancer Res. 3: 365-371. doi:10.1158/1541-7786. MCR-04-0117. PMID:16046547.
3. Casterella, P.J., and Teirstein, P.S. 1999. Prevention of coronary restenosis. Cardiol. Rev. 7: 219-231. doi:10.1097/00045415-199907000- 00014. PMID:10423674.
4. Denger, S., Jahn, L., Wende, P., Watson, L., Gerber, S.H., Kubler, W., and Kreuzer, J. 1999. Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis. Atherosclerosis, 144: 15-23. doi:10.1016/S0021-9150(99)00033-7. PMID:10381273.
5. Glukhova, M.A., Frid, M.G., and Koteliansky, V.E. 1991a. Phenotypic changes of human aortic smooth muscle cells during development and in the adult vessel. Am. J. Physiol. 261: 78-80. PMID:1928456.
6. Glukhova, M.A., Shekhonin, B.V., Kruth, H., and Koteliansky, V.E. 1991b. Expression of cytokeratin 8 in human aortic smooth muscle cells. Am. J. Physiol. 261: 72-77. PMID:1718173.
7. Haubner, R., Gratias, R., Diefenbach, B., Goodman, S.L., Jonczyk, A., and Kessler, H. 1996. Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin vβ3 antagonists. J. Am. Chem. Soc. 118: 7461-7472. doi:10.1021/ja9603721.
8. Hedin, U., Roy, J., Tran, P.K., Lundmark, K., and Rahman, A. 1999. Control of smooth muscle cell proliferation: the role of the basement membrane. Thromb. Haemost. 82(Suppl 1): 23-26. PMID:10695481.
9. Jahn, L., and Franke, W.W. 1989. High frequency of cytokeratin-producing smooth muscle cells in human atherosclerotic plaques. Differentiation, 40: 55-62. doi:10.1111/j.1432-0436.1989.tb00813.x. PMID:2472991.
10. Jahn, L., Kreuzer, J., von Hodenberg, E., Kubler, W., Franke, W.W., Allenberg, J., and Izumo, S. 1993. Cytokeratins 8 and 18 in smooth muscle cells. Detection in human coronary artery, peripheral vascular, and vein graft disease and in transplantation-associated arteriosclerosis. Arterioscler. Thromb. 13: 1631-1639. PMID:7692956.
11. Johansson, B., Eriksson, A., Virtanen, I., and Thornell, L.E. 1997. Intermediate filament proteins in adult human arteries. Anat. Rec. 247: 439-448. doi:10.1002/(SICI)1097-0185(199704) 247:4〈439::AID-AR1〉3.0. CO;2-M. PMID:9096782.
12. Johansson, B., Eriksson, A., and Thornell, L.E. 1999. Intermediate filament proteins in developing human arteries. Anat. Embryol. (Berl.), 199: 225-231. doi:10.1007/s004290050223. PMID:10068088.
13. Lesma, E., Grande, V., Carelli, S., Brancaccio, D., Canevini, M.P., Alfano, R.M., et al. 2005. Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor. Am. J. Pathol. 167: 1093-1103. PMID: 16192644.
14. Li, S., Moon, J.J., Miao, H., Jin, G., Chen, B.P., Yuan, S., et al. 2003. Signal transduction in matrix contraction and the migration of vascular smooth muscle cells in three-dimensional matrix. J. Vasc. Res. 40: 378-388. doi:10.1159/000072702. PMID: 12891007.
15. Merne, M., and Syrjanen, S. 2003. The mesenchymal substrate influences the epithelial phenotype in a three-dimensional cell culture. Arch. Dermatol. Res. 295: 190-198. doi:10.1007/s00403-003-0419-2. PMID:12898149.
16. Moon, M.C., Molnar, K., Yau, L., and Zahradka, P. 2004. Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury. J. Vasc. Surg. 40: 130-137. doi:10.1016/j.jvs. 2004.02.031. PMID:15218473.
17. Sakata, N., Kawamura, K., Fujimitsu, K., Chiang, Y.Y., and Takebayashi, S. 1990. Immunocytochemistry of intermediate filaments in cultured arterial smooth muscle cells: differences in desmin and vimentin expression related to cell of origin and/or plating time. Exp. Mol. Pathol. 53: 126-139. doi:10.1016/0014-4800(90)90037-E. PMID:2261944.
18. Saward, L., and Zahradka, P. 1997. Coronary artery smooth muscle in culture: migration of heterogeneous cell populations from vessel wall. Mol. Cell. Biochem. 176: 53-59. doi:10.1023/A:1006870827516. PMID:9406145.
19. Simons, M., Leclerc, G., Safian, R.D., Isner, J.M., Weir, L., and Baim, D.S. 1993. Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy. N. Engl. J. Med. 328: 608-613. doi:10.1056/NEJM199303043280903. PMID:8429852.
20. Slomp, J., Gittenberger-de Groot, A.C., Koteliansky, V.E., Glukhova, M.A., Bogers, A.J., and Poelmann, R.E. 1997. Cytokeratin expression in human arteries pertinent to intimal thickening formation in the ductus arteriosus. Differentiation, 61: 305-311. doi:10.1046/j.1432-0436.1997.6150305.x. PMID:9342841.
21. Uenishi, T., Kubo, S., Yamamoto, T., Shuto, T., Ogawa, M., Tanaka, H., et al. 2003. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 94: 851-857. doi:10.1111/j.1349- 7006.2003.tb01366.x. PMID: 14556657.
22. Wilson, D.P., Saward, L., Zahradka, P., and Cheung, P.K. 1999. Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model. Cardiovasc. Res. 42: 761-772. doi:10.1016/S0008-6363(98)00340-X. PMID:10533617.
23. Yau, L., Elliot, T., Lalonde, C., and Zahradka, P. 1998. Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase. Eur. J. Biochem. 253: 91-100. doi:10.1046/j.1432-1327.1998. 2530091.x. PMID:9578465.
24. Zahradka, P., Harding, G., Litchie, B., Thomas, S., Werner, J.P., Wilson, D.P., and Yurkova, N. 2004. Activation of MMP-2 in response to vascular injury is mediated by phosphatidylinositol 3-kinase-dependent expression of MT1-MMP. Am. J. Physiol. Heart Circ. Physiol. 287: H2861-H2870. doi:10.1152/ajpheart.00230.2004. PMID:15297252.